Your topics. New publications.

A compact browser notification when there’s something new. At most once a day — no account needed.

What interests you?

Optional and switchable off here at any time. We save your selected topics and device subscription; no email address is required. Privacy

Search the harborEN/DEAccount
Nutrition foundations
Research brief

Methionine-supplemented low-protein diet in mice: growth hormone, GLP-1, FGF21 and frailty

In mice, a low-protein longevity diet supplemented with methionine reduced fat mass and frailty and improved cardiometabolic markers; it lowered IGF-1 and raised growth hormone, GLP-1 and FGF21. An epidemiological cross-sectional analysis linked highest animal protein intake to about double the prevalence of type 2 diabetes. [1]

Automatic summary · not editorially reviewed

The key findings

  1. In mice, western and ketogenic diets increased fat mass and frailty, whereas a low-protein longevity diet supplemented with methionine reduced fat mass and frailty and improved cardiometabolic markers. [1]

  2. The methionine-supplemented diet lowered IGF-1 and raised growth hormone, GLP-1 and FGF21; FGF21 was required for fat loss and insulin sensitivity. [1]

  3. In a cross-sectional analysis of over 200,000 men and women, the highest animal protein intake group had approximately double the prevalence of type 2 diabetes compared with the lowest intake group. [1]

The source at a glance

Study type / format
Animal diet study plus cross-sectional epidemiological analysis (abstract)
Population / context
Mice fed different diets, plus over 200,000 men and women in an epidemiological cross-sectional analysis.
Summary based on
Study abstract
Original publication
June 23, 2026

Diets tested in mice for healthspan and strength

The researchers examined different diets to find compositions that promote both healthspan and strength in mice. The western and ketogenic diets increased fat mass and frailty and raised either cholesterol or insulin resistance. A low-protein longevity diet modeled on the traditional Mediterranean and Okinawan diets, but supplemented with methionine (LDMM), instead reduced fat mass and frailty while improving cardiometabolic markers.

Supporting source [1]

Hormone changes and FGF21 requirement in LDMM mice

LDMM reduced insulin-like growth factor 1 (IGF-1) while increasing growth hormone, GLP-1 and fibroblast growth factor 21 (FGF21). FGF21 was required for the fat loss and insulin sensitivity seen with this diet. Separately, bimonthly cycles of a 4-day fasting-mimicking diet improved metabolic markers.

Supporting source [1]

Animal protein intake and type 2 diabetes prevalence

A cross-sectional analysis of epidemiological data from over 200,000 men and women found that those with the highest animal protein intake tended to have a healthier lifestyle but had approximately double the prevalence of type 2 diabetes compared with the lowest intake group. The authors conclude that mostly plant-based low-amino-acid diets have the most potent effects on healthspan but require moderate methionine intake to minimize frailty.

Supporting source [1]

How to interpret this

Abstract only; the full text was not reviewed. The diet and hormone findings come from mice, not humans, and do not establish human lifespan or healthspan benefits. The epidemiological result is a cross-sectional association, not evidence of cause and effect.

Based on the study abstract; the full paper, tables and supplementary data were not reviewed.

Source & supporting passages

[1]
Methionine-supplemented longevity diet increases growth hormone, GLP-1, and FGF21; reduces frailty; and promotes healthspan.

Fanti M, Brandhorst S, Navarrete G, Diaz A, Giuliani G, Chowdhury D, Antunes GC, Morgan TE, Dubeau L, Villani V, Perin L, Malik VS, Hu FB, Longo VD. · europepmc.org · June 23, 2026

Read the quoted passagesIn the language of the original source
  1. Finding 1 ↑

    reduced fat mass and frailty while improving
  2. Finding 2 ↑

    which was required for fat loss and
  3. Finding 3 ↑

    approximately double the prevalence of type 2

AI-assisted summary with linked source passages. No independent editorial or clinical review.

Our editorial method

Discussion

Community discussions

0 topics

Member contributions. Share sources, disclose commercial interests, and avoid personal medical or dosing advice.

Loading…